Independent Director · Edgewise Therapeutics, Inc. (EWTX)

Jonathan C. Fox, M.D., Ph.D director compensation at Edgewise: $349K

Fiscal year 2025 director compensation for Jonathan C. Fox, M.D., Ph.D at Edgewise Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 23, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Jonathan C. Fox, M.D., Ph.D’s full pay file as a PDF — free

More than this page: up to 10 years of Jonathan’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Jonathan C. Fox, M.D., Ph.D and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Edgewise Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Edgewise Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$45,000$0$304,477—$349,477
FY2024$43,579—$247,738—$291,317
FY2022—————

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Edgewise Therapeutics, Inc. DEF 14A filed April 23, 2026, accession 0001104659-26-047688, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Edgewise Therapeutics, Inc. filed document, accession 0001104659-26-047688. Every figure is read from that document and cited to the page and table it appears in. Filed April 23, 2026.

Get the Edgewise Therapeutics Board Governance Report

$349,477 Jonathan C. Fox, M.D., Ph.D, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 23, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Edgewise Therapeutics pays directors a $40,000 cash retainer and $350,000 in Options.

Committees

FY2025 · as the proxy prints them

Audit

The rest of the Edgewise Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Arlene M. MorrisIndependent Director$361,977
Badreddin Edris, Ph.DIndependent Director$359,477
Christopher MartinIndependent Director$704,712
Jonathan Root, M.DIndependent Director$359,477
Laura BregeIndependent Director$371,977
Peter Thompson, M.DDirector$384,477

The full Edgewise Therapeutics compensation record

free company brief

This page is one director within Edgewise Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order EWTX

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report